Register now: https://www.biospectrumasia.com/webinar-biosimilarcytiva
What to Expect:
Proven strategies for developing serum-free, single-cell cloning workflows
Insights into fine-tuning media to empower production goals
Regulatory intelligence for smoother development and submission
Practical perspectives from seasoned experts in biosimilar CLD
Speakers Include:
Melanie Sorensen, Regulatory Affairs Strategist Leader
Nan Lin, PhD, Director, New Technologies & Cell Culture Service Applications
Sheffali Dash, Principal Scientist, CLD & Cell Culture Services
Why Attend:
Whether you're navigating regulatory bottlenecks or striving to enhance manufacturing yield, this session provides you with actionable insights to optimize your biosimilar development from the ground up.
Register now: https://www.biospectrumasia.com/webinar-biosimilarcytiva
